Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism.

Creekmore FM, Oderda GM, Pendleton RC, Brixner DI.

Pharmacotherapy. 2006 Oct;26(10):1438-45.

PMID:
16999654
2.

Incidence of thrombocytopenia in hospitalized patients with venous thromboembolism.

Stein PD, Hull RD, Matta F, Yaekoub AY, Liang J.

Am J Med. 2009 Oct;122(10):919-30. doi: 10.1016/j.amjmed.2009.03.026. Review.

PMID:
19682670
3.

Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients.

Junqueira DR, Perini E, Penholati RR, Carvalho MG.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD007557. doi: 10.1002/14651858.CD007557.pub2. Review.

PMID:
22972111
4.

Fondaparinux for thromboembolic treatment and prophylaxis of heparin-induced thrombocytopenia.

Efird LE, Kockler DR.

Ann Pharmacother. 2006 Jul-Aug;40(7-8):1383-7. Review.

PMID:
16788093
5.

Pharmacoeconomics of low-molecular-weight heparins: limitations of studies comparing them to unfractionated heparin.

Jones TE, Smith BJ, Polasek JF.

Expert Opin Pharmacother. 2004 Sep;5(9):1887-97. Review.

PMID:
15330727
6.

Major bleeding rates after prophylaxis against venous thromboembolism: systematic review, meta-analysis, and cost implications.

Muntz J, Scott DA, Lloyd A, Egger M.

Int J Technol Assess Health Care. 2004 Fall;20(4):405-14. Review.

PMID:
15609788
7.

Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.

Kanaan AO, Silva MA, Donovan JL, Roy T, Al-Homsi AS.

Clin Ther. 2007 Nov;29(11):2395-405. Review.

PMID:
18158080
8.

Economic considerations in the prevention and treatment of venous thromboembolism.

Hawkins D.

Am J Health Syst Pharm. 2004 Dec 1;61(23 Suppl 7):S18-21. Review.

PMID:
15597575
9.

Decreased prevalence of heparin-induced thrombocytopenia with low-molecular-weight heparin and related drugs.

Walenga JM, Jeske WP, Prechel MM, Bacher P, Bakhos M.

Semin Thromb Hemost. 2004 Feb;30 Suppl 1:69-80. Review.

PMID:
15085468
10.

Incidence and diagnosis of heparin-induced thrombocytopenia (HIT) in patients with traumatic injuries treated with unfractioned or low-molecular-weight heparin: a literature review.

Bloemen A, Testroote MJ, Janssen-Heijnen ML, Janzing HM.

Injury. 2012 May;43(5):548-52. doi: 10.1016/j.injury.2011.05.007. Review.

PMID:
21640991
11.

Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.

Holzheimer RG.

Eur J Med Res. 2004 Apr 30;9(4):225-39. Review.

PMID:
15210403
12.

Risk assessment and prophylaxis of venous thromboembolism in acutely and/or critically ill patients.

Davidson BL.

Haemostasis. 2000;30 Suppl 2:77-81; discussion 63. Review.

PMID:
11251346
13.

Heparin-induced thrombocytopenia in surgical patients.

Battistelli S, Genovese A, Gori T.

Am J Surg. 2010 Jan;199(1):43-51. doi: 10.1016/j.amjsurg.2009.01.029. Review.

PMID:
20103065
14.
15.

Venous thromboembolism prophylaxis with unfractionated heparin in the hospitalized medical patient: the case for thrice daily over twice daily dosing.

Mahan CE, Pini M, Spyropoulos AC.

Intern Emerg Med. 2010 Aug;5(4):299-306. doi: 10.1007/s11739-010-0359-8. Review.

PMID:
20177819
16.

Pharmacological prevention of venous thromboembolism in medical patients at risk.

Wolozinsky M, Yavin YY, Cohen AT.

Am J Cardiovasc Drugs. 2005;5(6):409-15. Review.

PMID:
16259529
17.

Low-molecular-weight heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review.

Ribic C, Lim W, Cook D, Crowther M.

J Crit Care. 2009 Jun;24(2):197-205. doi: 10.1016/j.jcrc.2008.11.002. Review.

PMID:
19327323
18.
19.

[Thrombosis prophylaxis with heparins in intensive care patients].

Greinacher A, Janssen D.

Anasthesiol Intensivmed Notfallmed Schmerzther. 2005 Mar;40(3):156-63. Review. German.

PMID:
15770559
20.

Heparin-induced thrombocytopenia: clinical manifestations and management strategies.

Menajovsky LB.

Am J Med. 2005 Aug;118 Suppl 8A:21S-30S. Review.

PMID:
16125511
Items per page

Supplemental Content

Support Center